Viatris Inc. (VTRS) Stock Grade

About Viatris Inc.'s fundamentals

Viatris is a specialty and generic drug manufacturer with a market capitalization of $14.6 billion that is currently unprofitable, reporting a net loss in its latest annual statement and a net margin of -24.6%. The company's revenue declined 3.0% year-over-year, indicating contraction in its core business. Despite the accounting losses, Viatris generated positive free cash flow, which supports its dividend yield of 3.8%. The company's financial metrics suggest operational challenges alongside some cash-generating capacity.